What is the recommended management for a 34‑week pregnant woman with hypertension?

Management of Hypertensive Pregnancy at 34 Weeks

At 34 weeks gestation with hypertension, initiate antihypertensive therapy if BP is consistently ≥140/90 mmHg, using extended-release nifedipine or labetalol as first-line agents, with a target diastolic BP of 85 mmHg (systolic 110-140 mmHg). 1

Blood Pressure Thresholds and Urgent Treatment

Severe Hypertension (>160/110 mmHg)

• Requires immediate treatment in a monitored setting 1
• Use oral nifedipine, IV labetalol, or IV hydralazine
• Oral labetalol acceptable if other agents unavailable

Non-Severe Hypertension (≥140/90 mmHg)

• Treat consistently elevated BP at or above this threshold 1
• Target diastolic BP: 85 mmHg (office)
• Target systolic BP: 110-140 mmHg
• Reduce or cease medications if diastolic BP falls <80 mmHg 1

First-Line Antihypertensive Medications

Extended-release nifedipine and labetalol are the preferred first-line agents 2:

Nifedipine (Often Preferred)

• Use long-acting formulation for maintenance
• Once-daily dosing improves adherence
• Switch to labetalol if patient experiences headaches, tachycardia, or edema
• Can combine with labetalol for uncontrolled BP

Labetalol

• Alternative to nifedipine or used in combination
• Contraindicated in reactive airway disease 2
• May require TID or QID dosing due to accelerated pregnancy metabolism
• Minimal risks: potential fetal growth restriction, bradycardia, hypoglycemia (no teratogenicity reported) 2

Methyldopa

• Second-line option, particularly in resource-limited settings
• Only medication with long-term infant outcome data 2
• Less effective than β-blockers and calcium channel blockers for preventing severe hypertension 2

Contraindicated Medications

Never use ACE inhibitors, ARBs, mineralocorticoid receptor antagonists, or direct renin inhibitors due to fetal teratogenicity and oligohydramnios 2

Assessment and Monitoring Strategy

Initial Hospital Assessment Required

• Evaluate for preeclampsia features (proteinuria, end-organ involvement) 1
• Confirm fetal well-being with ultrasound
• Assess for neurological signs (headache, visual changes, clonus)

If Preeclampsia Diagnosed

Maternal monitoring includes 1:

• BP monitoring (continuous initially, then regular intervals)
• Proteinuria assessment if not already present
• Clinical examination including clonus assessment
• Twice weekly blood tests minimum: hemoglobin, platelets, liver enzymes, renal function, uric acid

Fetal monitoring includes 1:

• Serial ultrasound surveillance if fetal growth restriction present
• Regular fetal well-being assessments

Outpatient Management Criteria

After initial hospital assessment, stable patients may be managed as outpatients if 1:

• Condition is stable
• Patient can reliably report problems
• Patient can monitor BP at home

Magnesium Sulfate for Seizure Prophylaxis

Administer magnesium sulfate if the patient has 1:

• Preeclampsia with proteinuria AND severe hypertension, OR
• Hypertension with neurological signs or symptoms

Delivery Timing at 34 Weeks

At 34 weeks gestation, expectant management is generally appropriate unless specific maternal or fetal indications for delivery exist 1, 3:

Indications for Immediate Delivery at 34 Weeks

Deliver if any of the following develop 1:

• Repeated severe hypertension despite 3 classes of antihypertensives
• Progressive thrombocytopenia
• Progressively abnormal liver or renal function tests
• Pulmonary edema
• Severe intractable headache, repeated visual scotomata, or convulsions
• Non-reassuring fetal status

Expectant Management Considerations

• Planned delivery at 37 weeks is recommended for preeclampsia 1
• Between 34-37 weeks, balance maternal benefits against neonatal risks 3
• Planned early delivery reduces composite maternal mortality and morbidity 3
• However, early delivery increases respiratory distress syndrome (RR 2.24) and NICU admission (RR 1.65) 3

Critical Pitfalls to Avoid

1. Do not delay treatment waiting for BP to reach 160/110 mmHg—treat at ≥140/90 mmHg consistently 1
2. Do not over-treat—reduce medications if diastolic BP <80 mmHg 1
3. Do not use short-acting nifedipine for maintenance—only for acute severe hypertension 2
4. Do not prescribe labetalol to patients with asthma or reactive airway disease 2
5. Do not assume all hypertension is benign at 34 weeks—assess for preeclampsia features immediately 1

Algorithm Summary

1. Measure BP accurately (office ≥140/90 or home ≥135/85)
2. Assess for preeclampsia (proteinuria, labs, symptoms)
3. Initiate first-line antihypertensive (extended-release nifedipine or labetalol)
4. Target diastolic 85 mmHg, systolic 110-140 mmHg
5. Monitor twice weekly if preeclampsia (labs, BP, fetal status)
6. Give magnesium sulfate if severe features or neurological symptoms
7. Deliver at 37 weeks if stable preeclampsia, or immediately if severe features develop